TCR2 Therapeutics Inc.
TCRR · NASDAQ
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$40 | -$61 | -$31 | -$32 |
| Dep. & Amort. | $1 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | -$0 |
| Stock-Based Comp. | $1 | $3 | $3 | $3 |
| Change in WC | -$3 | $5 | $1 | $9 |
| Other Non-Cash | $3 | $27 | -$0 | -$0 |
| Operating Cash Flow | -$40 | -$25 | -$26 | -$20 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$2 | -$5 | -$6 |
| Net Acquisitions | $0 | $15 | $0 | $0 |
| Inv. Purchases | -$14 | -$52 | -$30 | -$38 |
| Inv. Sales/Matur. | $35 | $58 | $70 | $34 |
| Other Inv. Act. | $1 | -$15 | $0 | $0 |
| Investing Cash Flow | $22 | $4 | $36 | -$10 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | -$0 |
| Financing Cash Flow | $0 | $0 | $0 | -$0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$18 | -$21 | $10 | -$30 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $34 | $55 | $45 | $75 |
| End Cash | $16 | $34 | $55 | $45 |
| Free Cash Flow | -$40 | -$27 | -$31 | -$26 |